Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 10
- CBD Market
America’s CBD Industry Now Faces Same Evidential Battle Europe Has Been Fighting for 8 Years
The long and arduous journey to regulate cannabidiol (CBD) in Europe, which began in 2018 with the European Union’s classification of CBD as a ‘novel food’, is now playing out in the courtrooms of the United States.
- Hemp Industry
DEA Formalises HHC Ban as US Farm Bill Offers No Repreive for Cannabinoid Market
As the federal campaign to clamp down on intoxicating hemp in the US rolls on, the Drug Enforcement Administration (DEA) has officially designated hexahydrocannabinol (HHC) a Schedule I substance.
- CBD Market
The War on Europe’s Legal Hemp Industry
In April 2025, the Italian government used emergency constitutional powers to bypass parliament and reclassify non-intoxicating hemp as a narcotic, regardless of THC content, following multiple failed attempts to decimate the industry.
- Pharmaceutical
German Distributor Fette Pharma Emerges From Restructuring Under New Investor Leadership
German medicinal cannabis distributor Fette Pharma GmbH has reported the successful completion of a strategic restructuring, almost seven months after an investor consortium led by entrepreneur Jörg Löser acquired the Egelsbach-based company in September 2025.
- Interviews
‘Thoughtful, Prudent, Patient’ – Why Village Farms Is Sitting Out the M&A Rush
The M&A scramble for Europe has continued at a fearsome pace over the last few weeks.
- M&A Activity
Has Rescheduling Accelerated the Cannabis M&A Wave?
Last week’s rescheduling announcement has placed a spotlight firmly on the medical cannabis arms of North America’s largest operators.
- Investment & Finance
The Fight for Cannabis Rescheduling Is Far From Over
Last week’s rescheduling announcement came as a surprise to many, not least to us here at Business of Cannabis.
- Policy & Regulation
The US Officially Reschedules Cannabis, Partly….
After years of false starts, political delays and administrative paralysis, the United States federal government has taken its first concrete step toward rescheduling cannabis.
- Investment & Finance
Federal Agencies Reportedly Told to Prep for Imminent Cannabis Rescheduling Announcement
Cannabis stocks have once again been sent flying in the wake of the latest hint of progress on cannabis rescheduling from Trump’s White House.
- Industry Trends
Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics.
- Hemp Industry
Eight Years After Decriminalisation, South Africa’s Cannabis Industry Edges Towards Regulated Market
South Africa, according to its own government, already has a cannabis industry worth up to R28bn (£1.28bn).
- Interviews
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
